日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis

斑马鱼体内因子VIII的缺失可以重新平衡抗凝血酶缺乏症，但出血倾向有限。

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024013143
Raghunath, Azhwar; Richter, Catherine E; Griffin, Megan S; Emly, Sylvia M; Yaman, Murat; Arruda, Valder R; Samelson-Jones, Benjamin J; Shavit, Jordan A
发表日期：2025
文献求助 收藏

Ancient origin of the furin sequence in the wolf F8 gene

狼F8基因中弗林蛋白酶序列的古老起源

期刊:Open Veterinary Journal
影响因子:1
doi:10.5455/OVJ.2025.v15.i7.32
Siner, Joshua I; Barber-Meyer, Shannon; Samelson-Jones, Benjamin J; Mech, Lucyan David; Arruda, Valder R; Crudele, Julie M
发表日期：2025
文献求助 收藏

AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of life

针对患有严重血友病的伴侣犬的AAV基因疗法：关于免疫原性、疗效和生活质量的真实世界长期数据

期刊:Molecular Therapy-Methods & Clinical Development
影响因子:4.7
doi:10.1016/j.omtm.2024.101205
Doshi, Bhavya S; Samelson-Jones, Benjamin J; Nichols, Timothy C; Merricks, Elizabeth P; Siner, Joshua L; French, Robert A; Lee, Ben J; Arruda, Valder R; Callan, Mary Beth
免疫/内分泌
发表日期：2024
文献求助 收藏

Characteristics of BAY 2599023 in the Current Treatment Landscape of Hemophilia A Gene Therapy

BAY 2599023 在当前 A 型血友病基因治疗治疗格局中的特征

期刊:Current Gene Therapy
影响因子:3.3
doi:10.2174/1566523222666220914105729
Pipe, Steven W; Arruda, Valder R; Lange, Claudia; Kitchen, Stephen; Eichler, Hermann; Wadsworth, Samuel
基因治疗
发表日期：2023
文献求助 收藏

Immune complications and their management in inherited and acquired bleeding disorders

遗传性和获得性出血性疾病的免疫并发症及其治疗

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2022016530
Arruda, Valder R; Lillicrap, David; Herzog, Roland W
免疫/内分泌
发表日期：2022
文献求助 收藏

B cell-activating factor modulates the factor VIII immune response in hemophilia A.

B 细胞激活因子调节 A 型血友病中的 VIII 因子免疫反应

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI142906
Doshi Bhavya S, Rana Jyoti, Castaman Giancarlo, Shaheen Mostafa A, Kaczmarek Radoslaw, Butterfield John Ss, Meeks Shannon L, Leissinger Cindy, Biswas Moanaro, Arruda Valder R
细胞生物学
发表日期：2021
文献求助 收藏

Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?

为什么AAV FVIII基因疗法至今尚未获得美国食品药品监督管理局的批准？

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021004760
Arruda, Valder R
发表日期：2021
文献求助 收藏

Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants

对凝血因子IX Padua和其他高比活性变体的进化见解

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2019000405
Samelson-Jones, Benjamin J; Finn, Jonathan D; Raffini, Leslie J; Merricks, Elizabeth P; Camire, Rodney M; Nichols, Timothy C; Arruda, Valder R
发表日期：2021
文献求助 收藏

Gene Therapy for Inherited Bleeding Disorders

基因疗法治疗遗传性出血性疾病

期刊:Seminars in Thrombosis and Hemostasis
影响因子:4.1
doi:10.1055/s-0041-1722862
Arruda, Valder R; Weber, Jesse; Samelson-Jones, Benjamin J
发表日期：2021
文献求助 收藏

Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A

AAV肝脏靶向因子VIII基因疗法诱导免疫耐受治疗A型血友病的转化潜力

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2020.00618
Samelson-Jones, Benjamin J; Arruda, Valder R
免疫/内分泌
发表日期：2020
文献求助 收藏